Sage Journals: Discover world-class research

Open access

Review article

First published 2017-5

Factors associated with efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer

Shaohua Cui, Liyan Jiang

Tumor Biology

Retricted access

Review article

First published 2016-6

Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation–positive non-small cell lung cancers: an update for recent advances in therapeutics

Clement Chung

Journal of Oncology Pharmacy Practice

Free access

Review article

First published 2015-10

Clinical approaches to treat patients with non-small cell lung cancer and epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance

Alfredo Tartarone, Rosa Lerose

Therapeutic Advances in Respiratory Disease

Retricted access

Review article

First published 2018-7

Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation

Meredith K Bollinger, Amanda S Agnew, Gerard P Mascara

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2014-2

Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors

Lei Dong, Zhao-feng Han, Zi-hui Feng [...]

Journal of International Medical Research

Retricted access

Research article

First published 2023-9

Combination of available topical beta-blockers and antibiotic ointment for epidermal growth factor receptor tyrosine kinase inhibitor-induced paronychia and pseudopyogenic granulomas in Taiwan

Hui-Lin Liu, Cheng-Hao Chuang, Chin-Ling Chen [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2025

External Application of a Xiaozhen zhiyang Decoction for Facial Rash Related to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Chinese Patients: A Prospective Single-Arm Observational Study

Jietao Lin, Lingling Sun, Jing Zhang [...]

Integrative Cancer Therapies

Retricted access

Research article

First published 2003-12

Gefitinib (ZD1839,Iressa®): a selective epidermal growth factor receptor-tyrosine kinase inhibitor

Sachin R Shah, Tracey L Walsh, Casey B Williams [...]

Journal of Oncology Pharmacy Practice

Open access

Case report

First published 2023

A case of epidermal growth factor receptor tyrosine kinase inhibitor effectiveness in epidermal growth factor receptor mutation-positive squamous cell carcinoma

Sosuke Matsumura, Satoshi Ano, Norihiro Kikuchi [...]

Sage Open Medical Case Reports

Retricted access

Research article

First published 2010-08

Rational Approach to the Synthesis,Evaluation,and 68 Ga Labeling of a Novel 4-Anilinoquinoline Epidermal Growth Factor Receptor Inhibitor as a New Imaging Agent That Selectively Targets the Epidermal Growth Factor Receptor Tyrosine Kinase

Chumpol Theeraladanon, Nobukazu Takahashi, Masaaki Shiina [...]

Cancer Biotherapy and Radiopharmaceuticals

Search results